Ali Behbahani - Jun 7, 2021 Form 4 Insider Report for Oyster Point Pharma, Inc. (OYST)

Role
Director
Signature
/s/ Sasha Keough, attorney-in-fact
Stock symbol
OYST
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 08:52 PM
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OYST Common Stock Award $0 +3.47K +52.52% $0.00 10.1K Jun 7, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OYST Stock Option (Right to Buy) Award $0 +5.2K $0.00 5.2K Jun 7, 2021 Common Stock 5.2K $17.74 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 The shares underlying the RSU will vest on June 7, 2022, but will vest fully on the date of the next annual stockholder meeting held after the date of grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date.
F3 The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 7, 2021 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date.